Ania M. Moradkhani
Ania M. Moradkhani publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Biotechnology, on topics such as Sarcoma Diagnosis and Treatment, CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers.
- World rank
- #4,197,112 of 7,710,434 ranked researchers
- Rank in United States
- #1,133,571 of 1,627,098
- Works
- 31
- Citations
- 142
- Citations per work
- 4.6
What does Ania M. Moradkhani research?
Ania M. Moradkhani's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2579.4%
- Medicine2579.4%
- Everything else414.1%
- Life Sciences26.5%
- 1Oncology40% of their works
- 2Pulmonary and Respiratory Medicine27% of their works
- 3Biotechnology6% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Cardiology and Cardiovascular Medicine3% of their works
- 6Gastroenterology3% of their works
Research topics
Which keywords describe Ania M. Moradkhani's research?
The keywords of their largest research topics: Chemotherapy, Prognostic Factors, Osteosarcoma, Soft Tissue Sarcoma, Immunotherapy, Tumor Regression, Lymphoma and CAR T Cells.
- Sunitinib
- Imatinib Mesylate
- Molecular Profiling
- Tumor Targeting
- Bacterial Therapy
- PET Imaging
- Immune Checkpoint Blockade
- CAR T Cells
- Tumor Regression
- Soft Tissue Sarcoma
- Prognostic Factors
- Chemotherapy
- Osteosarcoma
- Immunotherapy
- Lymphoma
- Chimeric Antigen Receptor
- PD-1 and PD-L1
- Angiosarcoma
- Epithelioid Hemangioendothelioma
- Classification
- Cetuximab
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy242 topics
- Prognostic Factors242 topics
- Osteosarcoma211 topic
- Soft Tissue Sarcoma211 topic
- Immunotherapy202 topics
- Tumor Regression202 topics
- Lymphoma192 topics
- CAR T Cells151 topic
- Chimeric Antigen Receptor151 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- PET Imaging72 topics
- Angiosarcoma51 topic
- Bacterial Therapy51 topic
- Epithelioid Hemangioendothelioma51 topic
- Tumor Targeting51 topic
- Classification41 topic
- Molecular Profiling41 topic
- Cetuximab31 topic
- Imatinib Mesylate31 topic
- KRAS Mutations31 topic
- Sunitinib31 topic
Where does Ania M. Moradkhani work?
Ania M. Moradkhani's main affiliation in the publication record is Sarcoma Oncology Center, United States.
How many publications and citations does Ania M. Moradkhani have?
OpenAlex counts 31 works and 142 citations for Ania M. Moradkhani, an h-index of 6, ranking #4,197,112 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ania M. Moradkhani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.